1 Table Of Contents 2 1.1 List of Tables 8 1.2 List of Figures 9 2 Executive Summary 11 2.1 The Diabetes Care Devices Market in Emerging Countries (China, India, Brazil) is Forecast to Reach $1.7 billion by 2017 11 2.2 China is the Largest Diabetes Care Devices Market among Emerging Countries 12 2.3 Insulin Delivery Devices Market is the Largest Category in the Diabetes Care Devices Market in Emerging Countries 13 2.4 Novo Nordisk and Roche Lead the Diabetes Care Devices Market in Emerging Countries 13 2.5 Increase in Number of Diabetes Awareness and Prevention Programs to Drive the Diabetes Care Devices Market in Emerging Countries 14 3 Introduction 15 3.1 GBI Research Guidance 15 4 Disease Overview: Diabetes 17 4.1 Type 1 Diabetes 17 4.1.1 Introduction 17 4.1.2 Etiology, Disease Symptoms and Risk Factors 17 4.2 Type 2 Diabetes 17 4.2.1 Introduction 17 4.2.2 Etiology, Disease Symptoms and Risk Factors 18 4.2.3 Epidemiology 18 5 Diabetes Care Devices, Emerging Countries: Market Characterization 20 5.1 Diabetes Care Devices Market, Emerging Countries (China, India, Brazil), Revenue ($m), 2003–2010 20 5.2 Diabetes Care Devices Market, Emerging Countries (China, India, Brazil), Revenue ($m), 2010–2017 22 5.3 Diabetes Care Devices Market, Emerging Countries (China, India, Brazil), Company Share (%), 2010 24 5.3.1 Diabetes Care Devices Market, China, Company Share (%), 2010 25 5.3.2 Diabetes Care Devices Market, India, Company Share (%), 2010 27 5.3.3 Diabetes Care Devices Market, Brazil, Company Share (%), 2010 28 5.4 Diabetes Care Devices, Emerging Countries: Market Dynamics 30 5.4.1 Market Drivers 30 5.4.1.1 India and China as Largest Diabetic Prevalent Countries in the World to Drive the Diabetes Care Devices Market 30 5.4.1.2 Increased Per Capita Spending Coupled with Increasing Healthcare Expenditure to Provide Growth Opportunities for Diabetes Care Devices Market 32 5.4.1.3 Increase in Number of Diabetes Awareness and Prevention Programs to Drive the Diabetes Care Devices Market 33 5.4.1.4 Increasing Demand for Glucose Monitoring, Insulin Pens in Home Care to Drive Diabetes Care Devices Market 35 5.4.2 Market Restraints 36 5.4.2.1 Low Uptake of Healthcare Insurance to Slow Down Diabetes Care Devices Market 36

5.4.2.2 Cultural Preferences among the Elderly Population for Traditional Remedies may Effect Market Growth in Emerging Countries 37 5.4.2.3 Regular Maintenance, Risk of Infection and Associated Pain Raise Patient Concerns about the Adoption of Diabetes Care Devices 38 6 Diabetes Care Devices Market, Emerging Countries: Category Analysis 39 6.1 Insulin Delivery Devices: Overview 39 6.1.1 Insulin Pens 39 6.1.2 Traditional Insulin Pump Accessories 39 6.1.3 Traditional Insulin Pumps 39 6.1.4 Insulin Syringes 40 6.2 Insulin Delivery Devices Market, Emerging Countries, Revenue ($m), 2003–2017 40 6.2.1 Insulin Delivery Devices Market, China, Revenue ($m), 2003–2010 40 6.2.2 Insulin Delivery Devices Market, China, Revenue ($m), 2010–2017 42 6.2.3 Insulin Delivery Devices Market, India, Revenue ($m), 2003–2010 43 6.2.4 Insulin Delivery Devices Market, India, Revenue ($m), 2010–2017 44 6.2.5 Insulin Delivery Devices Market, Brazil, Revenue ($m), 2003–2010 45 6.2.6 Insulin Delivery Devices Market, Brazil, Revenue ($m), 2010–2017 46 6.3 Insulin Delivery Devices Market, Emerging Countries, Company Share (%), 2010 47 6.3.1 Insulin Delivery Devices Market, China, Company Share (%), 2010 47 6.3.2 Insulin Delivery Devices Market, India, Company Share (%), 2010 48 6.3.3 Insulin Delivery Devices Market, Brazil, Company Share (%), 2010 49 6.4 Insulin Delivery Devices, Emerging Countries, Market Dynamics 50 6.4.1 Market Drivers 50 6.4.1.1 Affordability and Ease of Administration make Insulin Pens the Preferred Choice of Insulin Delivery Devices 50 6.4.1.2 Increase in the Incidence of Childhood Insulin Dependent Diabetes to Boost the Market Growth of Insulin Delivery devices 50 6.4.2 Market Restraint 52 6.4.2.1 High Cost to be a Major Deterrent to Widespread Adoption of Insulin Pumps 52 6.4.2.2 Complications due to Insulin Pump Failure can Slow their Adoption 52 6.5 Glucose Monitoring Devices: Overview 53 6.5.1 Blood Glucose Meters 53 6.5.1.1 Traditional Glucose Meters 54 6.5.1.2 Continuous Glucose Monitoring (CGM) Systems 54 6.5.2 Blood Glucose Test Strips 54 6.5.3 Lancets 54 6.6 Glucose Monitoring Devices, Emerging Countries, Revenue ($m), 2003–2017 54 6.6.1 Glucose Monitoring Devices Market, China, Revenue ($m), 2003–2010 54 6.6.2 Glucose Monitoring Devices Market, China, Revenue ($m), 2010–2017 56 6.6.3 Glucose Monitoring Devices Market, India, Revenue ($m), 2003–2010 57 6.6.4 Glucose Monitoring Devices Market, India, Revenue ($m), 2010–2017 57 6.6.5 Glucose Monitoring Devices Market, Brazil, Revenue ($m), 2003–2010 58 6.6.6 Glucose Monitoring Devices Market, Brazil, Revenue ($m), 2010–2017 59 6.7 Glucose Monitoring Devices Market, Emerging Countries, Company Share (%), 2010 61 6.7.1 Glucose Monitoring Devices Market, China, Company Share (%), 2010 61

6.7.2 Glucose Monitoring Devices Market, India, Company Share (%), 2010 62 6.7.3 Glucose Monitoring Devices Market, Brazil, Company Share (%), 2010 63 6.8 Glucose Monitoring Devices, Emerging Countries, Market Dynamics 64 6.8.1 Market Drivers 64 6.8.1.1 Large Diabetic Population and Expanding Private Healthcare Facilities to Drive Glucose Monitoring Devices Market 64 6.8.1.2 Increasing Demand for CGM Systems in Intensive Care Units (ICU) to Drive Growth of Glucose Monitoring Devices Market 65 6.8.2 Market Restraints 65 6.8.2.1 High Cost and Reimbursement Concerns is a Growth Limiting Factor for Glucose Monitoring Devices Market. 65 6.8.2.2 Pain Associated with Blood Glucose Meters Reduces Patient Compliance 65 7 Diabetes Care Devices Market, Emerging Countries (China, India, Brazil): Competitive Assessment 67 7.1 Diabetes Care Devices Market, China, Competitive Assessment, 2010 67 7.2 Diabetes Care Devices Market, India, Competitive Assessment, 2010 67 7.3 Diabetes Care Devices Market, Brazil, Competitive Assessment, 2010 68 8 Diabetes Care Devices Market, Emerging Countries: Key Market Participants 69 8.1 F. Hoffmann-La Roche Ltd. 69 8.1.1 Overview 69 8.1.2 Marketed Products, Diabetes Care Devices 70 8.2 LifeScan, Inc. (Johnson & Johnson) 70 8.2.1 Overview 70 8.2.2 Marketed Products, Diabetes Care Devices 70 8.3 Novo Nordisk A/S 71 8.3.1 Overview 71 8.3.2 Marketed Products, Diabetes Care Devices 71 8.4 Medtronic, Inc. 71 8.4.1 Overview 71 8.4.2 Marketed Products, Diabetes Care Devices 72 8.5 Abbott Laboratories 72 8.5.1 Overview 72 8.5.2 Marketed Products, Diabetes Care Devices 72 8.6 Bayer HealthCare AG 73 8.6.1 Overview 73 8.6.2 Marketed Products, Diabetes Care Devices 73 8.7 Becton, Dickinson and Company 73 8.7.1 Overview 73 8.7.2 Marketed Products, Diabetes Care Devices 74 8.8 Sanofi 74 8.8.1 Overview 74 8.8.2 Marketed Products, Diabetes Care Devices 74 8.9 Eli Lilly and Company 75 8.9.1 Overview 75 8.9.2 Marketed Products, Diabetes Care Devices 75 8.10 Hindustan Syringes & Medical Devices Ltd. 75

8.10.1 Overview 75 8.10.2 Marketed Products, Diabetes Care Devices 75 9 Diabetes Care Devices, Emerging Countries (China, India, Brazil): Pipeline Assessment 76 9.1 Diabetes Care Devices, Emerging Countries (China, India, Brazil), Pipeline Products Summary 76 9.1.1 MIT-P-I 76 9.1.1.1 Product Description 76 9.1.1.2 Product Status 76 9.1.2 Mylife OmniPod 77 9.1.2.1 Product Description 77 9.1.2.2 Product Status 77 9.1.3 V Pump 77 9.1.3.1 Product Description 77 9.1.3.2 Product Status 77 9.1.4 Patch Insulin Pump 78 9.1.4.1 Product Description 78 9.1.4.2 Product Status 78 9.1.5 Spring Hybrid Patch Pump 78 9.1.5.1 Product Description 78 9.1.5.2 Product Status 78 9.1.6 ClikSTAR 79 9.1.6.1 Product Description 79 9.1.6.2 Product Status 79 9.1.7 BGStar 79 9.1.7.1 Product Description 79 9.1.7.2 Product Status 79 10 Diabetes Care Devices Market, Emerging Countries (China, India, Brazil): Deals Analysis 81 10.1 Diabetes Care Devices Market, Mergers and Acquisitions, Emerging Countries (China, India, Brazil), 2007–2011 81 10.2 Key Deals, Diabetes Care Devices Market, 2007–2011 81 10.2.1 MicroPort Medical Acquires Beijing Pangerui Medical 81 10.2.1.1 Description 81 10.2.1.2 Deal Rationale 81 11 Appendix 82 11.1 Definitions 82 11.1.1 Diabetes Care Devices 82 11.1.2 Glucose Monitoring 82 11.1.3 Blood Glucose Meters 82 11.1.3.1 Continuous Glucose Monitoring Systems (CGM) 82 11.1.3.2 Traditional Glucose Meters 82 11.1.4 Blood Glucose Test Strips 82 11.1.5 Lancets 82 11.1.6 Insulin Delivery 82 11.1.7 Insulin Pens 83

11.1.7.1 Disposable Insulin Pens 83 11.1.7.2 Pen Needles 83 11.1.7.3 Reusable Insulin Pens 83 11.1.8 Insulin Pumps 83 11.1.8.1 Disposable Insulin Pumps 83 11.1.8.2 Traditional Insulin Pumps 83 11.1.9 Insulin Syringes 83 11.1.10 Traditional Insulin Pump Accessories 84 11.2 Acronyms 84 11.3 Sources 85 11.4 Research Methodology 85 11.5 Secondary Research 86 11.6 Primary Research 86 11.7 Models 87 11.8 Forecasts 87 11.9 Expert Panels 87 11.10 Contact Us 87 11.11 Disclaimer 88 1.1